Airtel has launched an affordable plan priced at Rs. 26, which will be very useful for data-intensive users. This new addition is a part of Airtel's affordable recharge plan portfolio.
US COVID updated boosters: The White House release stated that now have vaccines for all three primary seasonal respiratory viruses- COVID-19, flu, and RSV.
The fifth vaccine, GEMCOVAC-OM, was developed with assistance from Mission COVID Suraksha, which was carried out by DBT and BIRAC as part of Atmanirbhar Bharat 3.0, the government's package to accelerate the development of COVID-19 vaccines.
Covid-19: Earlier on October 17, Prakash Kumar Singh, director of government and regulatory affairs at SII, submitted a market authorization application to the Drug Controller General of India (DCGI) for the heterologous booster dose of Covovax.
COVID-19 booster dose: Bharat Biotech applied in September for DCGI approval for market authorisation of "Five Arms" intranasal heterologous booster dose.
COVID-19: According to HAS, the three vaccines approved include those of Moderna and of Pfizer/BioNTech targetting the Omicron variant BA.1, and that of Pfizer/BioNTech adapted for the BA.4 and BA.5 Omicron subvariants, Xinhua news agency reported.
Covid news: Corbevax will be in addition to the existing guidelines for homologous precaution dose administration of Covaxin and Covishield vaccines.
In April this year, the Japanese government announced including Covaxin in its list of recognized vaccines to further facilitate travel from India.
Covid booster dose: The drive, aimed at boosting the uptake of Covid precaution doses, will be held as part of the government's Azadi Ka Amrit Mahotsav to celebrate the 75th anniversary of India's Independence, they said.
The Standing Technical Sub-Committee (STSC) of the NTAGI had earlier recommended reducing the gap between the second and precaution doses of COVID-19 vaccines from the current nine to six months, official sources said.
The government advisory panel, which met on Thursday, also reviewed the findings of a study by the Christian Medical College (CMC) in Vellore on the feasibility of allowing as a precaution dose a Covid vaccine different from the one used for primary vaccination.
The findings of the study have been published on Tuesday on bioRxiv, a pre-print server and have not been peer-reviewed.
At present, the gap between the second Covid jab and the precaution dose is nine months.
The eligible people can get the booster shot, which currently costs Rs 250 plus service charges, free of cost at any government hospital or dispensary, the statement said.
"There may be need for yet again another boost- in this case, a 4th-dose boost for an individual receiving mRNA- that could be based on age, as well as underlying conditions," Dr Fauci said.
In his speech at the Davos Agenda, a virtual event being held this week by the World Economic Forum, Bancel said this date was a "best case scenario", but that he believed it was possible for some countries next year, CNN reported.
In South Africa, the Omicron variant replaced the other viruses within a few weeks and led to a sharp increase in the number of cases diagnosed. Analyses in various countries indicate that the doubling time for cases is approximately 2 to 4 days. Omicron has been detected in dozens of countries, including France, and became dominant by the end of 2021.
Covaxin ( BBV152) booster, India's indigenous vaccine, has shown that it can neutralize both Omicron and Delta variants of SARS-CoV-2, jab maker Bharat Biotech informed on Wednesday.
The scientists from KU Leuven began by testing nine monoclonal antibodies used in clinical practice or currently in preclinical development. "We now need to study the length of protection of the booster dose. The vaccines probably become less effective in offering protection against contracting the virus, but they should continue to protect against severe forms," explained Olivier Schwartz.
From January 10, India will start administering the precautionary dose of the vaccine to healthcare workers, frontline workers and those above 60 years of age with comorbidities.
Top News
Latest News
